Cytokinetics (CYTK) Current Assets (2016 - 2025)
Historic Current Assets for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $1.0 billion.
- Cytokinetics' Current Assets rose 8143.43% to $1.0 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.0 billion, marking a year-over-year increase of 8143.43%. This contributed to the annual value of $628.1 million for FY2023, which is 2101.84% down from last year.
- Latest data reveals that Cytokinetics reported Current Assets of $1.0 billion as of Q3 2024, which was up 8143.43% from $1.1 billion recorded in Q2 2024.
- In the past 5 years, Cytokinetics' Current Assets registered a high of $1.1 billion during Q2 2024, and its lowest value of $219.0 million during Q2 2020.
- Moreover, its 5-year median value for Current Assets was $586.6 million (2023), whereas its average is $592.2 million.
- As far as peak fluctuations go, Cytokinetics' Current Assets surged by 13701.36% in 2020, and later plummeted by 3651.12% in 2023.
- Over the past 5 years, Cytokinetics' Current Assets (Quarter) stood at $474.2 million in 2020, then grew by 12.96% to $535.7 million in 2021, then soared by 48.45% to $795.2 million in 2022, then fell by 21.02% to $628.1 million in 2023, then skyrocketed by 62.18% to $1.0 billion in 2024.
- Its Current Assets was $1.0 billion in Q3 2024, compared to $1.1 billion in Q2 2024 and $638.7 million in Q1 2024.